3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
55
Stomach Neoplasms
27
Pancreatic Neoplasms
17
Rectal Neoplasms
16
Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
11
Neoplasm Metastasis
10
Esophageal Squamous Cell Carcinoma
8
Esophageal Neoplasms
8
Colonic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Carcinoma, Hepatocellular
8
Adenocarcinoma
8
Head and Neck Neoplasms
7
Biliary Tract Neoplasms
6
Adenocarcinoma Of Esophagus
6
Ovarian Neoplasms
5
Gastrointestinal Neoplasms
5
Peritoneal Neoplasms
4
Advanced Solid Tumors
4
Urinary Bladder Neoplasms
3
Nasopharyngeal Carcinoma
3
Lung Neoplasms
3
Endometrial Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma
3
Breast Neoplasms
3
Appendiceal Neoplasms
3
Locally Recurrent Rectal Cancer
2
Interventions
Carboplatin
4
pertuzumab
2
durvalumab
2
Tretinoin
2
Trastuzumab
2
Standard of Care
2
Paclitaxel
2
Oxaliplatin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
toripalimab
1
tislelizumab
1
talazoparib
1
sarilumab
1
relugolix
1
regorafenib
1
pexidartinib
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
nimotuzumab
1
neratinib
1
ganitumab
1
enzalutamide
1
dostarlimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pathologic Complete Response
×
Fluorouracil
×
Clear all
NCT05000697
2024-11-27
CCHOWW
Hospital Alemão Oswaldo Cruz
Phase NA
Recruiting
216 enrolled